Cancer Registry Software Market
Cancer Registry Software Market - Global Industry Assessment & Forecast
#
Pages:
150
2022
May - 2022
VMR-1610
Segments Covered
By
Type Standalone Software, Integrated Software
-
By
Deployment Model On-Premise, Cloud-Based
-
By
Database Commercial Databases, Public Databases
-
By
Functionality Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies
-
By
End-User Government Organizations & Third-Party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centers
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 56.42 Billion |
 Revenue 2030:
|
USD 108.38 Billion |
 Revenue CAGR
(2023 - 2030): |
8.50% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2017 to 2021 |
| 3. | Forecast Data | 2023 to 2030 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
Vantage Market
Research | 02-Jun-2022
FAQ
Frequently Asked Question
What is the global demand for Cancer Registry Software in terms of revenue?
-
The global Cancer Registry Software valued at USD 56.42 Billion in 2022 and is expected to reach USD 108.38 Billion in 2030 growing at a CAGR of 8.50%.
Which are the prominent players in the market?
-
The prominent players in the market are Elekta (Sweden), Electronic Registry Systems Inc. (US), Onco Inc. (US), C/NET Solutions (US), Rocky Mountain Cancer Data Systems (US), McKesson Corporation (US).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.50% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cancer Registry Software include
- Growing Prevalence of Cancer and Favorable Government Initiatives
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cancer Registry Software in 2022.
